| JYHB1800552 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2018-05-18 | 默克雪兰诺有限公司 | Merck Serono Co Ltd;Merck KGaA;Merck Serono GmbH | Certificate Issued | 2018-07-17 | view |
| JYHB1090003 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2010-07-06 | 德国柏林化学股份有限公司北京办事处 | Berlin Chemical GmbH Beijing Office;Berlin-Chemie AG | Certificate Issued | 2011-02-21 | view |
| JYHB2001984 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2020-10-13 | | Berlin-Chemie AG | Filed | 2020-10-30 | view |
| JYHS2300085 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-07-13 | | Intas Pharmaceuticals Ltd;Chongqing Lummy Pharmaceuticals Company Limited | | | view |
| JTH1900041 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Disposable Import Drug Application | 2019-02-18 | Merck KGaA | Merck KGaA;Merck Serono Co Ltd;Merck Serono GmbH | Certificate Issued | 2019-03-12 | view |
| JYHB1100158 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2011-03-30 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA;Merck Serono GmbH | Certificate Issued | 2011-09-23 | view |
| JYHB0701148 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2007-11-28 | 德国默克公司 | Merck KGaA | Certificate Issued | 2008-10-21 | view |
| JYHS2200097 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2022-12-08 | | Lindopharm GmbH;Shenzhen China Resources Gosun Pharmaceuticals Co Ltd;Aristo Pharma GmbH | | | view |
| CYHS2400925 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs(4) | Generic Drug | 2024-03-27 | | Beijing Foyou Pharma Co Ltd;Zhejiang Aisheng Pharmaceutical Co Ltd | | | view |
| JYHB1900946 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2019-07-31 | 默克雪兰诺有限公司 | Merck Serono Co Ltd;Merck KGaA;Merck Serono GmbH | Filed | 2019-08-14 | view |
| JYHB2300200 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2023-03-28 | | Merck Sante SAS;Merck Healthcare KGaA | | | view |
| JYHB1700189 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2017-02-27 | 默克雪兰诺有限公司 | Merck Serono Co Ltd;Merck Sante SAS;Merck KGaA | Certificate Issued | 2019-09-29 | view |
| JYHZ0900228 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | License Renew | 2009-07-03 | 德国柏林化学股份有限公司北京办事处 | Berlin Chemical GmbH Beijing Office;Berlin-Chemie AG | Certificate Issued | 2010-02-09 | view |
| J0400174 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2004-02-18 | 德国默克公司 | Merck KGaA;Yabai Pharmaceuticals (China) Co Ltd | Approval Completed-Pending Certificated | 2004-05-10 | view |
| JYHB2000844 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2020-06-22 | 默克雪兰诺有限公司 | Merck Serono Co Ltd;Merck Sante SAS;Merck KGaA | Certificate Issued | 2020-07-27 | view |
| JYHS2300087 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-07-13 | | Intas Pharmaceuticals Ltd;Chongqing Lummy Pharmaceuticals Company Limited | | | view |
| JYHZ1800360 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | License Renew | 2018-11-19 | 默克雪兰诺有限公司 | Merck Serono Co Ltd;Merck KGaA;Merck Serono GmbH | Certificate Issued | 2019-07-03 | view |
| JYHZ1000194 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | License Renew | 2010-09-27 | 德国柏林化学股份有限公司北京办事处 | Berlin Chemical GmbH Beijing Office;Berlin-Chemie AG | Certificate Issued | 2011-04-18 | view |
| JYHB0600816 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2006-11-10 | 德国柏林化学股份有限公司北京办事处 | Berlin Chemical GmbH Beijing Office;Berlin-Chemie AG | Certificate Issued | 2008-07-18 | view |
| JYHB2101204 | 左甲状腺素钠片 | levothyroxine sodium | Tablet | Chemical Drugs | Supplementary Application | 2021-06-25 | | Merck Sante SAS;Merck KGaA | | | view |
